Lindus Health Ads

Hear from a sponsor running a large-scale diagnostic study with Lindus Health

SVP of Clinical Operations at Harbinger Health, Eric Haltom, on what it’s like to partner with Lindus Health on a large-scale oncology diagnostic study.

Learn how Lindus runs clinical studies differently

Next-generation CRO.

Delivering a fully decentralized trial with integrated recruitment systems

Dr. Jameel Muzaffar, Chief Science Officer at Oto, on Lindus Health delivering a fully decentralized clinical trial.

Learn how Lindus runs clinical studies differently

Next-generation CRO, with accountability built in.

Learn how Lindus runs clinical studies differently

Accountable Research Organization.

Hear from a sponsor running a large-scale diagnostic study with Lindus Health

SVP of Clinical Operations at Harbinger Health, Eric Haltom, on what it’s like to partner with Lindus Health on a large-scale oncology diagnostic study.

Large-scale liquid biopsy trials need purpose-built operational infrastructure

Dr. Paul Billings, Scientific Advisor at Lindus Health — with 40+ years in diagnostics including roles as CEO of Biological Dynamics and CMO of Natera — on Lindus Health’s capabilities in large-scale liquid biopsy screening trials.

Respiratory Evidence Generation & Innovation Best Practice - live KOL Webinar | Tuesday, March 24 | 12:00 PM ET / 4:00 PM GMT Beyond FEV1: Similar Efficacy, Different Outcome - Differentiating Respiratory Assets Through Innovative Patient-Centered Evidence. How to design and execute Phase 3b/4 and RWE programs that generate decision-grade evidence on competitive timelines. Global expert panel John Matthews (ReCode Therapeutics, Guy’s and St Thomas’ NHS Foundation Trust, Imperial College London), Professor John Hurst (UCL), Joanne Fletcher (ex GSK), Andrew Cournoyer (Precision AQ 🇺🇸 ), José Ramos, MEd, RRT, RPFT (Monitored Therapeutics, Inc. 🇺🇸 ) and Malcolm Fogarty (Lindus Health) will discuss how to build that evidence. If you’re navigating a crowded respiratory market and need your evidence strategy to do more than confirm efficacy, register here: https://lnkd.in/eGneHf7X When your efficacy data looks like everyone else’s, the coverage decision comes down to what else you can show. In respiratory biologics, multiple asthma and COPD assets now report similar FEV1 improvements and exacerbation rates while competing for the same formulary positions. The window for differentiation is narrow - and increasingly determined by real-world effectiveness. The assets that secure favorable coverage are both clinically strong and backed by evidence strategies designed for payor and HTA decision-making from the start. Which therapies: • reduce ED visits • lower steroid burden • show treatment persistence across broad, diverse patient populations. Getting there means understanding what physicians, payors, and regulators weigh when results look similar, what’s now measurable outside the clinic through tools like remote spirometry and digital biomarkers, and how to design and execute Phase 3b/4 and RWE programs that generate decision-grade evidence on competitive timelines. To join the discussion Tuesday, March 24 | 12:00 PM ET / 4:00 PM GMT register here: https://lnkd.in/eGneHf7X

What rigorous CRO evaluation looks like from the sponsor side

Aharona Shuali, VP Medical at Nucleix, on evaluating and working with Lindus Health as their CRO partner.

Live Webinar: Beyond FEV1 — Building the Evidence Package Payors Require

When multiple biologics show comparable FEV1, coverage decisions turn on the quality of your real-world evidence package. On Tuesday March 24, join respiratory clinical developers, payor strategists, and RWE experts to discuss what HTA bodies and formulary committees require: • What payors and HTA bodies need to see in respiratory biologic submissions — and where current packages fall short • How to design Phase 3b, 4, and prospective RWE studies that capture endpoints like ED visit reduction, steroid burden, and treatment persistence • Where remote spirometry and digital biomarkers strengthen evidence for regulatory and HTA use If your programme is navigating a crowded respiratory market and your evidence strategy needs to do more than replicate pivotal trial findings, register below.

What operations leaders look for in a CRO partner

Eric Haltom, SVP of Clinical Operations at Harbinger Health, on partnering with Lindus to run an oncology diagnostic trial.

After the CRO dating game: what made the difference

Aharona Shuali, VP Medical at Nucleix, on evaluating and working with Lindus Health as their CRO partner.

Dedicated teams outperform split-focus CRO models

Eric Haltom, SVP of Clinical Operations at Harbinger Health, on partnering with Lindus to run an oncology diagnostic trial.

Hear from a sponsor running a large-scale diagnostic study with Lindus Health

SVP of Clinical Operations at Harbinger Health, Eric Haltom, on what it’s like to partner with Lindus Health on a large-scale oncology diagnostic study.

When your CRO delivers exactly what they promised in evaluation

Aharona Shuali, VP Medical at Nucleix, on evaluating and working with Lindus Health as their CRO partner.

Clear budget. Strong data management. In-house EDC.

Aharona Shuali, VP Medical at Nucleix, on evaluating and working with Lindus Health as their CRO partner.

Learn how Lindus runs clinical studies differently

Technology-powered CRO, with accountability built in.

In clinical trial proposals, there is often a structural incentive to understate risk. A sponsor issues an RFP for a study. Vendors respond with optimistic enrollment timelines to win the bid. Six months later, site activation lags, recruitment stalls, and the change orders arrive. This pattern repeats because the commercial incentive at the proposal stage rewards confidence over accuracy. Often, the CRO that presents the most aggressive timeline gets shortlisted. Whereas a CRO that documents dozens of operational risks with mitigation plans looks cautious by comparison. In my role developing commercial strategies for trial execution at Lindus, I spend significant time modeling these risks upfront. What’s the realistic drop-off rate between prescreening and consent for this population? What happens to the enrollment timeline if the IRB requires synchronous consent instead of asynchronous? What’s the coordinator FTE model if certain system integrations aren’t feasible? Tying pricing directly to trial milestones changes the dynamic. When both the CRO and the sponsor share the financial impact of a delayed first-patient-in, the feasibility conversation becomes more rigorous before the contract is signed. Both teams evaluate the protocol based on operational reality and historical performance data and we get to problem solve together as partners. I’m curious: how are sponsor-side teams weighing risk transparency against timeline confidence when evaluating competing proposals?

Hear from a sponsor running a large-scale diagnostic study with Lindus Health

SVP of Clinical Operations at Harbinger Health, Eric Haltom, on what it’s like to partner with Lindus Health on a large-scale oncology diagnostic study.

75% ahead of enrollment projections

Eric Haltom, SVP of Clinical Operations at Harbinger Health, on partnering with Lindus to run an oncology diagnostic trial.

Fully decentralized. On time. On budget.

Dr. Jameel Muzaffar, Chief Science Officer at Oto, on Lindus Health delivering a fully decentralized clinical trial.

Live Webinar: Beyond FEV1 — Innovative Study Design and Execution in Respiratory Evidence Generation

Respiratory Phase 3b, 4, and RWE studies are competing for the same sites, investigators, and patient populations — making enrollment harder and timelines tighter. On Tuesday March 24, join a panel of respiratory clinical developers, trial operations leaders, and diagnostic innovators to discuss what’s changing: • How to reach comorbid, polypharmacy, and community-based populations underrepresented in pivotal trials • Where remote spirometry and digital biomarkers are expanding what’s measurable in real-world settings • How novel study designs are capturing endpoints like treatment persistence and steroid burden with regulatory-grade rigor If you’re designing studies that need to do more than confirm efficacy — and do it on competitive timelines — register below.

Live Webinar: Beyond FEV1 — Translating Respiratory Efficacy Into a Value Story That Wins Coverage

When efficacy looks similar across a respiratory therapeutic class, the assets that achieve preferred formulary status are those with a more compelling value story — one grounded in outcomes payors and physicians use to differentiate. On March 24, join respiratory clinical developers, managed care leaders, and RWE experts to discuss how to build it: • Which patient-centered endpoints translate into payor-relevant outcomes in crowded respiratory markets • How to design studies that capture steroid burden, ED visit reduction, and treatment persistence with submission-grade rigor • What competitive differentiation looks like in practice — and where current evidence packages fall short If your asset needs a value story that holds up to HTA scrutiny and formulary review, register below.

Something we’ve started doing at Lindus is documenting operational risks in proposals with the same level of depth we’d document them in a clinical protocol - with likelihood, impact, and a mitigation plan for each. We’ve found that naming all risks upfront - whether it’s IRB timelines for eConsent approval, coordinator staffing assumptions, or medical record retrieval turnaround - changes the quality of the conversation with the sponsor before the contract is signed. Both teams end up aligning on which dependencies are on the critical path and what the contingency plan looks like if something slips. In a fully decentralized RCT where we enrolled over 2,000 participants per month, the velocity was partly a function of the enrollment architecture. But it was also a function of the fact that we’d mapped every operational dependency during proposal development and staffed accordingly. The operational plan matched reality because we’d been honest about the risks in the plan. Transparent risk documentation costs nothing and changes the trajectory of the study.

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Remote Research Opportunity - Academic Research From Home Taking antidepressants for MDD? Join our drug-free research study. Fully remote from home. Remote...

Lindus Health A Women's Health CRO that delivers everything needed to run a study from start to finish.

Lindus Health - International Clinical Trials Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more.

Lindus Health A Digital Therapeutics CRO - everything needed to run a study from start to finish.

End-to-End Medical Device CRO - Anti-CRO for Medical Devices Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more. Medical device trials don't have to be painful. 2X faster than other CROs. Fixed Pricing Model. About Us Top 5 Medical Device CROs

Lindus Health A Diagnostics CRO that delivers everything needed to run a study from start to finish.

International Clinical Trials - End-to- End CRO Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more. Rapid Diagnostics Trials CROs in Women's Health EU vs US Device Launch Trial Dropout in Psych Better Clinical Research

Laval CROs - End-to-End CRO Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more. EU vs US Device Launch } ( How do CH trials differ?

Award-winning Diagnostics CRO Delivering end-to-end diagnostic trial solutions with performance-based pricing

a www.lindushealth.com/ Lindus Health Lindus Health delivers end-to-end medical device trial solutions with fixed pricing

Lindus Health Infectious Disease CRO that delivers everything needed to run a study from start to finish

San Diego CROs - 2X Faster Than Other CROs Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more. A Medical Device CRO that delivers everything needed to run a study from start to finish.... Performance Based Pricing EU vs US Device Launch 5 Trends in Med Devices All-In-One Medical Device CRO

Medical device CRO - 2X Faster Than Other CROs Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more. All-In-One Medical Device CRO Expect Transparent Pricing Cosmetics Clinical Trials Evidence for Oncology Dx

Richmond CROs - End-to-End Medical Device CRO Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more. 73% faster...

Town 'n' Country CROs - ( Fixed pricing, incentive basi, Everything All-in-One: Recruitment, tecig Y a =, collection, data delivery, and more. Fixa S. RS

International Clinical Trials - Pittsburgh CROs Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more.

Not Your Typical CRO - 2X Faster Than Other CROs Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more. Fixed pricing, aligned... GLP-1 Agents Fixed pricing, incentive based International Clinical Trials Trial Dropout in Psych About Us

Earn $550 in Research Study - Paid Research - Remote Taking antidepressants for MDD? Join our drug-free research study. Fully remote from home. Remote...

Transparent Fixed Pricing - Johnson City CROs Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more.

Holmfirth CROs - International Clinical Trials Everything All-in-One: Recruitment, tec collection, data delivery, and more. Fixega. Better Clinical Trials in 2025 > Medical research companies > Top Infection CROs > About Us > Contact Us >

Sm’ www.lindushealth.com/ Fixed pricing, incentive based - Smart, Agile Study Design Everything All-in-One: Recruitment, tech, sites, data collection, data delivery, and more.

www.lindushealth.com/ Lindus Health A CRO that delivers everything needed to run a study from start to finish.

www.lindushealth.com/ Lindus Health A Diagnostics CRO that delivers everything needed to run a study from start to finish.

Lindus Health A Women's Health CRO that delivers everything needed to run a study from start to finish.